223 related articles for article (PubMed ID: 19923297)
1. Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1.
Eichler FS; Hornemann T; McCampbell A; Kuljis D; Penno A; Vardeh D; Tamrazian E; Garofalo K; Lee HJ; Kini L; Selig M; Frosch M; Gable K; von Eckardstein A; Woolf CJ; Guan G; Harmon JM; Dunn TM; Brown RH
J Neurosci; 2009 Nov; 29(46):14646-51. PubMed ID: 19923297
[TBL] [Abstract][Full Text] [Related]
2. Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1.
Garofalo K; Penno A; Schmidt BP; Lee HJ; Frosch MP; von Eckardstein A; Brown RH; Hornemann T; Eichler FS
J Clin Invest; 2011 Dec; 121(12):4735-45. PubMed ID: 22045570
[TBL] [Abstract][Full Text] [Related]
3. Mutant SPTLC1 dominantly inhibits serine palmitoyltransferase activity in vivo and confers an age-dependent neuropathy.
McCampbell A; Truong D; Broom DC; Allchorne A; Gable K; Cutler RG; Mattson MP; Woolf CJ; Frosch MP; Harmon JM; Dunn TM; Brown RH
Hum Mol Genet; 2005 Nov; 14(22):3507-21. PubMed ID: 16210380
[TBL] [Abstract][Full Text] [Related]
4. HSAN1 mutations in serine palmitoyltransferase reveal a close structure-function-phenotype relationship.
Bode H; Bourquin F; Suriyanarayanan S; Wei Y; Alecu I; Othman A; Von Eckardstein A; Hornemann T
Hum Mol Genet; 2016 Mar; 25(5):853-65. PubMed ID: 26681808
[TBL] [Abstract][Full Text] [Related]
5. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids.
Penno A; Reilly MM; Houlden H; Laurá M; Rentsch K; Niederkofler V; Stoeckli ET; Nicholson G; Eichler F; Brown RH; von Eckardstein A; Hornemann T
J Biol Chem; 2010 Apr; 285(15):11178-87. PubMed ID: 20097765
[TBL] [Abstract][Full Text] [Related]
6. Characterization of two mutations in the SPTLC1 subunit of serine palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I.
Rotthier A; Penno A; Rautenstrauss B; Auer-Grumbach M; Stettner GM; Asselbergh B; Van Hoof K; Sticht H; Lévy N; Timmerman V; Hornemann T; Janssens K
Hum Mutat; 2011 Jun; 32(6):E2211-25. PubMed ID: 21618344
[TBL] [Abstract][Full Text] [Related]
7. Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy.
Gantner ML; Eade K; Wallace M; Handzlik MK; Fallon R; Trombley J; Bonelli R; Giles S; Harkins-Perry S; Heeren TFC; Sauer L; Ideguchi Y; Baldini M; Scheppke L; Dorrell MI; Kitano M; Hart BJ; Cai C; Nagasaki T; Badur MG; Okada M; Woods SM; Egan C; Gillies M; Guymer R; Eichler F; Bahlo M; Fruttiger M; Allikmets R; Bernstein PS; Metallo CM; Friedlander M
N Engl J Med; 2019 Oct; 381(15):1422-1433. PubMed ID: 31509666
[TBL] [Abstract][Full Text] [Related]
8. A Model of Hereditary Sensory and Autonomic Neuropathy Type 1 Reveals a Role of Glycosphingolipids in Neuronal Polarity.
Cui M; Ying R; Jiang X; Li G; Zhang X; Zheng J; Tam KY; Liang B; Shi A; Göbel V; Zhang H
J Neurosci; 2019 Jul; 39(29):5816-5834. PubMed ID: 31138658
[TBL] [Abstract][Full Text] [Related]
9. A disease-causing mutation in the active site of serine palmitoyltransferase causes catalytic promiscuity.
Gable K; Gupta SD; Han G; Niranjanakumari S; Harmon JM; Dunn TM
J Biol Chem; 2010 Jul; 285(30):22846-52. PubMed ID: 20504773
[TBL] [Abstract][Full Text] [Related]
10. Precision mouse models of Yars/dominant intermediate Charcot-Marie-Tooth disease type C and Sptlc1/hereditary sensory and autonomic neuropathy type 1.
Hines TJ; Tadenev ALD; Lone MA; Hatton CL; Bagasrawala I; Stum MG; Miers KE; Hornemann T; Burgess RW
J Anat; 2022 Nov; 241(5):1169-1185. PubMed ID: 34875719
[TBL] [Abstract][Full Text] [Related]
11. SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins.
Lone MA; Aaltonen MJ; Zidell A; Pedro HF; Morales Saute JA; Mathew S; Mohassel P; Bönnemann CG; Shoubridge EA; Hornemann T
J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 35900868
[TBL] [Abstract][Full Text] [Related]
12. Novel HSAN1 mutation in serine palmitoyltransferase resides at a putative phosphorylation site that is involved in regulating substrate specificity.
Ernst D; Murphy SM; Sathiyanadan K; Wei Y; Othman A; Laurá M; Liu YT; Penno A; Blake J; Donaghy M; Houlden H; Reilly MM; Hornemann T
Neuromolecular Med; 2015 Mar; 17(1):47-57. PubMed ID: 25567748
[TBL] [Abstract][Full Text] [Related]
13. A Novel Variant (Asn177Asp) in SPTLC2 Causing Hereditary Sensory Autonomic Neuropathy Type 1C.
Suriyanarayanan S; Othman A; Dräger B; Schirmacher A; Young P; Mulahasanovic L; Hörtnagel K; Biskup S; von Eckardstein A; Hornemann T; Lone MA
Neuromolecular Med; 2019 Jun; 21(2):182-191. PubMed ID: 30955194
[TBL] [Abstract][Full Text] [Related]
14. A systematic comparison of all mutations in hereditary sensory neuropathy type I (HSAN I) reveals that the G387A mutation is not disease associated.
Hornemann T; Penno A; Richard S; Nicholson G; van Dijk FS; Rotthier A; Timmerman V; von Eckardstein A
Neurogenetics; 2009 Apr; 10(2):135-43. PubMed ID: 19132419
[TBL] [Abstract][Full Text] [Related]
15. Functional and Molecular Characterization of New
Rochat J; Blavier A; Ruet S; Vasseur S; Puma A; Desnous B; Chan V; Delmont E; Attarian S; Juntas Morales R; Quadrio I; Vidoni L; Bonello-Palot N; Cheillan D
Genes (Basel); 2024 May; 15(6):. PubMed ID: 38927628
[TBL] [Abstract][Full Text] [Related]
16. Hereditary sensory neuropathy type 1 mutations confer dominant negative effects on serine palmitoyltransferase, critical for sphingolipid synthesis.
Bejaoui K; Uchida Y; Yasuda S; Ho M; Nishijima M; Brown RH; Holleran WM; Hanada K
J Clin Invest; 2002 Nov; 110(9):1301-8. PubMed ID: 12417569
[TBL] [Abstract][Full Text] [Related]
17. Identification of dietary alanine toxicity and trafficking dysfunction in a Drosophila model of hereditary sensory and autonomic neuropathy type 1.
Oswald MC; West RJ; Lloyd-Evans E; Sweeney ST
Hum Mol Genet; 2015 Dec; 24(24):6899-909. PubMed ID: 26395456
[TBL] [Abstract][Full Text] [Related]
18. The pyridoxal 5'-phosphate (PLP)-dependent enzyme serine palmitoyltransferase (SPT): effects of the small subunits and insights from bacterial mimics of human hLCB2a HSAN1 mutations.
Beattie AE; Gupta SD; Frankova L; Kazlauskaite A; Harmon JM; Dunn TM; Campopiano DJ
Biomed Res Int; 2013; 2013():194371. PubMed ID: 24175284
[TBL] [Abstract][Full Text] [Related]
19. Substrate Availability of Mutant SPT Alters Neuronal Branching and Growth Cone Dynamics in Dorsal Root Ganglia.
Jun BK; Chandra A; Kuljis D; Schmidt BP; Eichler FS
J Neurosci; 2015 Oct; 35(40):13713-9. PubMed ID: 26446223
[TBL] [Abstract][Full Text] [Related]
20. Specific Deoxyceramide Species Correlate with Expression of Macular Telangiectasia Type 2 (MacTel2) in a SPTLC2 Carrier HSAN1 Family.
Wilson LMQ; Saba S; Li J; Prasov L; Miller JML
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
